General Session VI
Pelvic Veinous Disorders (PeVD) is a complex disease with various clinical profiles. The SVP classification of Pelvic Venous Disorders established by an international working group doesn’t appreciate nor the Pelvic Congestion Sydrom’s functional consequences neither its treatment efficiency.
Methods:
A specific quality of life test concerning the PeVD has been designed and applied before and after surgery.
66 consecutive patients underwent varicose pelvic veins embolization, and fulfilled the test before and 4 months after the surgery.
Results:
In the preoperative period, 98.5% of the patients had had at least one pregnancy (0-6), 70.8% had chronic pelvic pain, 68.2% had dyspareunia, 63.6% had lower limb symptoms, 60.6% had pelvic pain, 27.3% had vulvar varices, and 24.2% had PeVD without any lower limb symptom.
In the postoperative period we noticed a significant difference regarding: pre menstrual Syndrome, dyspareunia, heaviness and chronic pelvic pain worsened by prolonged standing, vulvar varices and lower limbs symptoms.
After embolization, only 4.5% of the patients still had symptoms. 10.6% of the patients had a recurrence of their symptoms, whose 42.8% of them had a clear of the symptoms after an iterative embolization of the remnant pelvic collaterals.
The only complication was a pulmonary coil migration without clinical consequences.
Conclusions:
PeVD treatment is the closure of pelvic leaking points by embolization.
As it is a functional surgery; it seems appropriate to offer an evaluation and standardized tool for the treatment procedure in order to allow the assessment of the efficiency of the treatment and the patients follow-up.
This work seems promising showing the improvement of the symptomatology after pelvic embolization.
The next step would be realizing a multicentric study.
jordane HERAIL, Dr
1
Clinique du Parc
LYON, Rhone-Alpes, France